Pharmaceuticals Global On demand · 24-48h

Global Squalene Supplement Market Strategic Research Report

Global Squalene Supplement Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Squalene Supplement Market
$1.85B2025
7.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Plant-based Squalene, Synthetic / Bio-fermented Squalene, Shark-derived Squalene

By Application: Online Sales, Offline Sales

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Icelandirect, Nature's Glory, Healthy Care, Orihiro, Wellness Resources, ATC Healthcare International Corporation, Australian by Nature, Natural Life, Spring Leaf, Meiriki, Voonka, New Zealand Pure Health

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 122 pages
Market size 2025
$1.85B
Billion USD
Forecast CAGR
7.8%
2025-2032
Forecast 2032
$3.1B
Projected
区域
5
Asia Pacific · Latin America · MEA · Europe · North America

概述

Scope of the Report

The global Squalene Supplement market size is predicted to grow from US$ 1,849 million in 2025 to US$ 3,134 million in 2032; it is expected to grow at a CAGR of 7.8% from 2026 to 2032.

Squalene supplements are dietary products formulated with squalene, a naturally occurring triterpene commonly derived from plant sources such as olive oil, sugarcane, or amaranth, and historically from shark liver oil. These supplements are consumed for their antioxidant properties and potential benefits related to cardiovascular health, immune support, skin health, and cellular protection. In 2025, the average retail price of squalene supplements is approximately US$45 per bottle, with global sales volume estimated at around 42 million bottles. The industry typically maintains a gross margin of 50%–70%, supported by branding, formulation differentiation, regulatory compliance costs, and the premium positioning of plant-based and sustainably sourced products. Downstream demand primarily comes from health-conscious consumers, aging populations, preventive healthcare users, and nutraceutical brands distributed through pharmacies, health stores, and e-commerce platforms.

Industry analysis shows that squalene supplements are increasingly positioned as premium, plant-based nutraceutical products rather than commodity oils. Competitive differentiation is driven by source transparency, sustainability certification, formulation purity, and integration into broader wellness portfolios, while regulatory compliance and consumer trust play a growing role in brand selection.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Squalene Supplement market?

What factors are driving Squalene Supplement market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Squalene Supplement market opportunities vary by end market size?

How does Squalene Supplement break out by Type, by Application?

This report presents a comprehensive overview of the global Squalene Supplement market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Plant-based Squalene
  • Synthetic / Bio-fermented Squalene
  • Shark-derived Squalene

Segment by Dosage Form

  • Softgel Capsule
  • Liquid Oil
  • Blended Formula

Segment by Packaging Size

  • Small Pack
  • Standard Pack
  • Value / Family Pack

Segment by Application

  • Online Sales
  • Offline Sales

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Squalene Supplement market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Online Sales, Offline Sales evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Squalene Supplement Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.85B
2025
Forecast
$3.1B
2032
CAGR
7.8%
2025–2032
区域
5
global
Key companies
IcelandirectNature's GloryHealthy CareOrihiroWellness ResourcesATC Healthcare International CorporationAustralian by NatureNatural Life
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Plant-based SqualeneSynthetic / Bio-fermented SqualeneShark-derived Squalene
By Application
Online SalesOffline Sales

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Plant-based Squalene
  • 3.1.3 Synthetic / Bio-fermented Squalene
  • 3.1.4 Shark-derived Squalene
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Online Sales
  • 4.1.3 Offline Sales
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Icelandirect
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Nature's Glory
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Healthy Care
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Orihiro
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Wellness Resources
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 ATC Healthcare International Corporation
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Australian by Nature
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Natural Life
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Spring Leaf
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Meiriki
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Voonka
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 New Zealand Pure Health
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Squalene Supplement market?
The global Squalene Supplement market is estimated at US$ 1.85 billion in 2025 (base year) and is projected to reach US$ 3.13 billion by 2032.
How fast is the Squalene Supplement market expected to grow?
The market is expected to grow at a CAGR of 7.8% from 2026 to 2032, expanding from US$ 1.85 billion in 2025 to US$ 3.13 billion in 2032, roughly 1.7 times its base-year value.
What does the Squalene Supplement market cover?
Squalene supplements are dietary products formulated with squalene, a naturally occurring triterpene commonly derived from plant sources such as olive oil, sugarcane, or amaranth, and historically from shark liver oil. These supplements are consumed for their antioxidant properties and potential benefits related to cardiovascular health, immune support, skin health, and cellular protection. In 2025, the average retail price of squalene supplements is approximately US$45 per bottle, with global sales volume estimated at around 42 million bottles.
What are the main segments of the Squalene Supplement market by type?
By type, the market is segmented into Plant-based Squalene, Synthetic / Bio-fermented Squalene and Shark-derived Squalene.
Which applications drive demand in the Squalene Supplement market?
Key applications covered include Online Sales and Offline Sales.
Who are the key players in the Squalene Supplement market?
Key players profiled include Icelandirect, Nature's Glory, Healthy Care, Orihiro, Wellness Resources, ATC Healthcare International Corporation, Australian by Nature and Natural Life, among 12 companies covered in total.
Which regions and countries are covered for Squalene Supplement?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Squalene Supplement market?
Competitive differentiation is driven by source transparency, sustainability certification, formulation purity, and integration into broader wellness portfolios, while regulatory compliance and consumer trust play a growing role in brand selection.
Who should buy the Squalene Supplement market report?
The report is intended for manufacturers and solution providers, distributors and end users in Online Sales and Offline Sales, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Squalene Supplement market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.